Role of Residue Phe225 in the Cofactor-Mediated, Allosteric Regulation of the Serine Protease Coagulation Factor VIIa
- 1 November 2000
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 39 (47) , 14457-14463
- https://doi.org/10.1021/bi0009486
Abstract
Functional regulation by cofactors is fundamentally important for the highly ordered, consecutive activation of the coagulation cascade. The initiating protease of the coagulation system, factor VIIa (VIIa), retains zymogen-like features after proteolytic cleavage of the activating Arg15−Ile16 peptide bond and requires the binding of the cofactor tissue factor (TF) to stabilize the protease domain in an active enzyme conformation. Structural comparison of TF-bound and free VIIa failed to provide a conclusive mechanism for this catalytic activation. This study provides novel insight into the cofactor-dependent regulation of VIIa by demonstrating that the side chain of Phe225, an aromatic residue that is common to allosterically regulated serine proteases, is necessary for optimal TF-mediated activation of VIIa's catalytic function. However, mutation of Phe225 did not abolish the cofactor-induced stabilization of the Ile16−Asp194 salt bridge, previously considered the primary switch mechanism for activating VIIa. Moreover, mutation of other residue side chains in the VIIa protease domain resulted in a reduced level of or no stabilization of the amino-terminal insertion site upon TF binding, with little or no effect on the TF-mediated enhancement of catalysis. This study thus establishes a crucial role for the aromatic Phe225 residue position in the allosteric network that transmits the activating switch from the cofactor interface to the catalytic cleft, providing insight into the highly specific conformational linkages that regulate serine protease function.Keywords
This publication has 12 references indexed in Scilit:
- Exosite Interactions Determine the Affinity of Factor X for the Extrinsic Xase ComplexPublished by Elsevier ,2000
- Crystal Structure of Active Site-Inhibited Human Coagulation Factor VIIa (des-Gla)Journal of Structural Biology, 1999
- Macromolecular Substrate Affinity for the Tissue Factor-Factor VIIa Complex Is Independent of Scissile Bond DockingJournal of Biological Chemistry, 1999
- Engineered Recombinant Factor VII Q217 Variants with Altered Inhibitor SpecificitiesBiochemistry, 1999
- Influence of cofactor binding and active site occupancy on the conformation of the macromolecular substrate exosite of factor VIIaJournal of Molecular Biology, 1998
- Molecular Mechanism of Tissue Factor-mediated Acceleration of Factor VIIa ActivityJournal of Biological Chemistry, 1996
- The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factorNature, 1996
- Recombinant soluble human tissue factor secreted by Saccharomyces cerevisiae and refolded from Escherichia coli inclusion bodies: glycosylation of mutants, activity and physical characterizationBiochemical Journal, 1995
- The Na+ Binding Site of ThrombinJournal of Biological Chemistry, 1995
- The transition of bovine trypsinogen to a trypsin-like state upon strong ligand bindingJournal of Molecular Biology, 1978